KELLI BRADBURY: Open Payments
NPI 1528159050 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,403 in 45 payments from 9 companies in 2025. Trend: 2023 $1,891 · 2024 $1,619 · 2025 $7,403
Speaker / faculty: $4,633Food & beverage: $1,516Travel & lodging: $1,254
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 14 | $6,351 |
| Amgen Inc. | 3 | $317 |
| Insulet Corporation | 13 | $234 |
| Novo Nordisk Inc | 8 | $184 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $125 |
| Novartis Pharmaceuticals Corporation | 2 | $103 |
| Mannkind Corporation | 1 | $47 |
| Sequel Med Tech, LLC | 1 | $26 |
| PFIZER INC. | 1 | $16 |
Products named: TZIELD, TEPEZZA, Omnipod, Kerendia, LEQVIO, AFREZZA, TWIIST, Ozempic.
Industry payments across KS — which companies pay providers there.
